PubMed · 2012 · 45 citations · 25 references
Life SciencesCell BiologyPharmacologyApoptosisCell SignalingMolecular OncologyApoptosis In CancerApoptosis ModulationApoptosis RegulationBcl-2 Family ProteinsCancer Cell SignalingHormonal Cancer TherapyApoptosis Signaling In CancerApoptotic Signaling In CancerCancer Cell ApoptosisCancer Cell Survival SignalingCancer Signaling PathwaysExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingWestern Blotting
AIM: The aim of the present study was to identify the mechanism by which genistein and 17β-estradiol inhibit proliferation of MDA-MB-231 breast cancer cells. MATERIALS AND METHODS: The expression of cell signaling proteins involved in cell apoptosis, proliferation, and survival (BCL-2 associated X protein, BAX; B-cell lymphoma 2, BCL-2; extracellular signal regulated kinase, pERK1/2; and protein kinase B, pAKT) were examined by western blotting, and tested whether these effects correlated with cell proliferation and apoptosis. RESULTS: Compared to the control, 1 μM genistein plus 1 nM 17β-estradiol significantly increased apoptosis, and the BAX/BCL-2 ratio, with a concomitant decrease in ERK1/2 phosphorylation. High concentrations of genistein (100 μM) both in the presence and absence of 17β-estradiol also increased apoptosis; however, these changes were not correlated with the BAX/BCL-2 ratio or with phosphorylation of ERK1/2. CONCLUSION: These results suggest that different concentrations of genistein elicit cell responses through different signaling mechanisms. These results are especially relevant in premenopausal women with breast cancer who are on a soy diet.
25
A simple technique for quantifying apoptosis in 96-well plates
Deborah Ribble, Nathaniel B. Goldstein, David A. Norris et al. · BMC Biotechnology · 2005 · 850 citations · Full text
Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein
Yiwei Li, Sunil Upadhyay, Mahbubur Bhuiyan et al. · Oncogene · 1999 · 319 citations